203 related articles for article (PubMed ID: 34586712)
21. [The incidence of oral candidiasis in patients with human immunodeficiency virus infection/acquired immunodeficiency syndrome from Yunnan, China].
Wen Y; Li C; Pei J; Bai J; Yang X; Duan K
Zhonghua Kou Qiang Yi Xue Za Zhi; 2014 Aug; 49(8):454-8. PubMed ID: 25351215
[TBL] [Abstract][Full Text] [Related]
22. Oral manifestations of HIV infection by gender and transmission category in Mexico City.
Ramirez-Amador V; Esquivel-Pedraza L; Sierra-Madero J; Ponce-de-Leon S; Ponce-de-Leon S
J Oral Pathol Med; 1998 Mar; 27(3):135-40. PubMed ID: 9563806
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of oral soft tissue lesions in HIV-infected minority children treated with highly active antiretroviral therapies.
Flanagan MA; Barasch A; Koenigsberg SR; Fine D; Houpt M
Pediatr Dent; 2000; 22(4):287-91. PubMed ID: 10969432
[TBL] [Abstract][Full Text] [Related]
24. Highly-active antiretroviral therapy and oral opportunistic microorganisms in HIV-positive individuals of Thailand.
Arirachakaran P; Poovorawan Y; Dahlén G
J Investig Clin Dent; 2016 May; 7(2):158-67. PubMed ID: 25537925
[TBL] [Abstract][Full Text] [Related]
25. Oral lesions and conditions associated with human immunodeficiency virus infection in 300 south Indian patients.
Ranganathan K; Reddy BV; Kumarasamy N; Solomon S; Viswanathan R; Johnson NW
Oral Dis; 2000 May; 6(3):152-7. PubMed ID: 10822358
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of oral mucosal lesions in adults undergoing highly active antiretroviral therapy in Hong Kong.
Perera M; Tsang PC; Samaranayake L; Lee MP; Li P
J Investig Clin Dent; 2012 Aug; 3(3):208-14. PubMed ID: 22573355
[TBL] [Abstract][Full Text] [Related]
27. Oral mucosal lesions and immune status in HIV-infected Indian children.
Subramaniam P; Kumar K
J Oral Pathol Med; 2015 Apr; 44(4):296-9. PubMed ID: 25212254
[TBL] [Abstract][Full Text] [Related]
28. Associated oral manifestations with HIV southeastern Brazilian patients on antiretroviral therapy.
Lustosa de Souza BK; Faé DS; Lemos CAA; Verner FS; Machado RA; Ortega RM; de Aquino SN
Braz J Otorhinolaryngol; 2023; 89(3):425-431. PubMed ID: 36813599
[TBL] [Abstract][Full Text] [Related]
29. Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy.
Schmidt-Westhausen AM; Priepke F; Bergmann FJ; Reichart PA
J Oral Pathol Med; 2000 Aug; 29(7):336-41. PubMed ID: 10947250
[TBL] [Abstract][Full Text] [Related]
30. Oral manifestations of HIV infection in 600 South African patients.
Arendorf TM; Bredekamp B; Cloete CA; Sauer G
J Oral Pathol Med; 1998 Apr; 27(4):176-9. PubMed ID: 9563573
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of oral lesions and periodontal diseases in HIV-infected patients on antiretroviral therapy.
Kroidl A; Schaeben A; Oette M; Wettstein M; Herfordt A; Häussinger D
Eur J Med Res; 2005 Oct; 10(10):448-53. PubMed ID: 16287607
[TBL] [Abstract][Full Text] [Related]
32. The association between a detectable HIV viral load and non-communicable diseases comorbidity in HIV positive adults on antiretroviral therapy in Western Cape, South Africa.
George S; McGrath N; Oni T
BMC Infect Dis; 2019 Apr; 19(1):348. PubMed ID: 31029087
[TBL] [Abstract][Full Text] [Related]
33. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS?
Ceballos-Salobreña A; Gaitán-Cepeda LA; Ceballos-Garcia L; Lezama-Del Valle D
AIDS Patient Care STDS; 2000 Dec; 14(12):627-35. PubMed ID: 11119429
[TBL] [Abstract][Full Text] [Related]
34. Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades.
Seoane Reula E; Bellon JM; Gurbindo D; Muñoz-Fernandez MA
Br J Dermatol; 2005 Aug; 153(2):382-9. PubMed ID: 16086754
[TBL] [Abstract][Full Text] [Related]
35. Oral health management of 97 patients living with HIV/AIDS in Ribeirão Preto, São Paulo, Brazil.
Silva DC; Lourenço AG; Ribeiro AE; Machado AA; Komesu MC; Motta AC
Braz Oral Res; 2015; 29():1-6. PubMed ID: 26313345
[TBL] [Abstract][Full Text] [Related]
36. Oral Candida colonization and its relation with predisposing factors in HIV-infected children and their uninfected siblings in Brazil: the era of highly active antiretroviral therapy.
Cerqueira DF; Portela MB; Pomarico L; de Araújo Soares RM; de Souza IP; Castro GF
J Oral Pathol Med; 2010 Feb; 39(2):188-94. PubMed ID: 20040023
[TBL] [Abstract][Full Text] [Related]
37. Oro-facial lesions and CD4 counts associated with HIV/AIDS in an adult population in Oyo State, Nigeria.
Adurogbangba MI; Aderinokun GA; Odaibo GN; Olaleye OD; Lawoyin TO
Oral Dis; 2004 Nov; 10(6):319-26. PubMed ID: 15533205
[TBL] [Abstract][Full Text] [Related]
38. Oral mucosal lesions and HIV viral load in the Women's Interagency HIV Study (WIHS).
Greenspan D; Komaroff E; Redford M; Phelan JA; Navazesh M; Alves ME; Kamrath H; Mulligan R; Barr CE; Greenspan JS
J Acquir Immune Defic Syndr; 2000 Sep; 25(1):44-50. PubMed ID: 11064503
[TBL] [Abstract][Full Text] [Related]
39. Oral mucosal status and salivary IgA levels of HIV-infected children.
Subramaniam P; Kumar K
J Oral Pathol Med; 2013 Oct; 42(9):705-10. PubMed ID: 23551639
[TBL] [Abstract][Full Text] [Related]
40. Gender differences in human immunodeficiency virus-related oral lesions: an Italian study.
Campisi G; Pizzo G; Mancuso S; Margiotta V
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):546-51. PubMed ID: 11346733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
